Medicare Enrolled

Dr. Kesha Wilford, M.D.

Neurology · Swedesboro, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
100 LEXINGTON RD, Swedesboro, NJ 08085
8564677360
Registered in NPPES since 2008
NPI: 1962677823 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wilford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wilford? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wilford

Dr. Kesha Wilford is a neurology specialist in Swedesboro, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Wilford performed 4,612 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Wilford received a total of $12,750 from 77 pharmaceutical and/or device companies across 769 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wilford is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 13% volume in NJ $12,750 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
4,612
Medicare services
Top 13% in NJ for neurology
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
4,100 $5 $11
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
192 $149 $395
New patient office visit, complex (60-74 min) 101 $183 $483
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
76 $43 $157
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
39 $26 $100
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $121 $364
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $104 $274
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
22 $58 $157
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
17 $120 $451
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
13 $98 $267
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,750
Total received (2018-2024)
Avg $1,821/year across 7 years
Top 21% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
769
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,025
2023
$923
2022
$1,805
2021
$2,126
2020
$1,411
2019
$3,225
2018
$2,236

Payments by company (2024)

MDD US Operations, LLC
$350
ABBVIE INC.
$199
UCB, Inc.
$38
Life Molecular Imaging Ltd
$33
Eisai Inc.
$33
Lilly USA, LLC
$33
IDORSIA PHARMACEUTICALS US INC
$32
Axsome Therapeutics, Inc.
$31
Amneal Pharmaceuticals LLC
$29
Amgen Inc.
$28
Takeda Pharmaceuticals U.S.A., Inc.
$20
REVANCE THERAPEUTICS, INC.
$19
Genentech USA, Inc.
$18
ACADIA Pharmaceuticals Inc
$18
Vanda Pharmaceuticals Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Ipsen Biopharmaceuticals, Inc
$17
Alnylam Pharmaceuticals Inc.
$17
Harmony Biosciences Llc
$16
Teva Pharmaceuticals USA, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
PFIZER INC.
$15
Aucta Pharmaceuticals, Inc.
$13
Top 3 companies account for 57.2% of 2024 payments
All-time payments by company (2018-2024) ›
Teva Pharmaceuticals USA, Inc.
$1,604
Supernus Pharmaceuticals, Inc.
$813
UCB, Inc.
$685
JAZZ PHARMACEUTICALS INC.
$537
Amgen Inc.
$502
Lilly USA, LLC
$488
Novartis Pharmaceuticals Corporation
$480
Sunovion Pharmaceuticals Inc.
$472
Harmony Biosciences LLC
$432
Avanir Pharmaceuticals, Inc.
$386
AbbVie Inc.
$375
Jazz Pharmaceuticals Inc.
$368
MDD US Operations, LLC
$350
ABBVIE INC.
$317
Eisai Inc.
$289
Biohaven Pharmaceutical Holding Company Ltd.
$275
Biohaven Pharmaceuticals, Inc.
$265
EISAI INC.
$253
ACADIA Pharmaceuticals Inc
$219
Acorda Therapeutics, Inc
$210
Amneal Pharmaceuticals LLC
$206
Ipsen Biopharmaceuticals, Inc
$198
PFIZER INC.
$166
Bausch Health US, LLC
$164
Biogen, Inc.
$159
Greenwich Biosciences, Inc.
$158
Allergan Inc.
$157
GENZYME CORPORATION
$152
Kyowa Kirin, Inc.
$146
Adamas Pharmaceuticals, Inc.
$131
IDORSIA PHARMACEUTICALS US INC
$104
HARMONY BIOSCIENCES LLC
$95
Allergan, Inc.
$92
Lundbeck LLC
$90
EMD Serono, Inc.
$83
Alexion Pharmaceuticals, Inc.
$75
Azurity Pharmaceuticals, Inc.
$70
Avion Pharmaceuticals
$66
CSL Behring
$62
Axsome Therapeutics, Inc.
$59
AstraZeneca Pharmaceuticals LP
$53
SK Life Science, Inc.
$52
Vertical Pharmaceuticals, LLC
$49
Impax Laboratories, Inc.
$48
Upsher-Smith Laboratories LLC
$47
IMPEL PHARMACEUTICALS INC.
$42
Neurelis, Inc.
$42
GE HealthCare
$41
UPSHER-SMITH LABORATORIES LLC
$40
Mallinckrodt Hospital Products Inc.
$34
GE HEALTHCARE
$34
Life Molecular Imaging Ltd
$33
Mallinckrodt Enterprises LLC
$33
Alnylam Pharmaceuticals Inc.
$31
Genentech USA, Inc.
$30
Merz Pharmaceuticals, LLC
$28
Vyera Pharmaceuticals, LLC
$26
BOSTON SCIENTIFIC CORPORATION
$22
ARBOR PHARMACEUTICALS, INC.
$21
Arbor Pharmaceuticals, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Neurocrine Biosciences, Inc.
$19
REVANCE THERAPEUTICS, INC.
$19
Boston Scientific Corporation
$19
SCILEX PHARMACEUTICALS INC.
$18
Vanda Pharmaceuticals Inc.
$18
W. L. Gore & Associates, Inc.
$17
AQUESTIVE THERAPEUTICS, INC.
$17
Resmed Corp
$16
Harmony Biosciences Llc
$16
PORTOLA PHARMACEUTICALS, LLC
$16
Otsuka America Pharmaceutical, Inc.
$16
Radius Health, Inc.
$14
CATALYST PHARMACEUTICALS, INC.
$14
ARGENX US, INC.
$13
Aucta Pharmaceuticals, Inc.
$13
Aprecia Pharmaceuticals, LLC
$11
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · AirSense · Austedo XR · BOTOX · BOTOX - SPASTICITY · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · Briviact · COMIRNATY · COPAXONE · Cimzia · DAXXIFY · DUOPA · DYSPORT · Daraprim Tablet 25mg · Dhivy · Dysport · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · Fintepla · Fycompa · GAUCHER-DISEASE · GENERAL DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · General - DBS · Gocovri · HYQVIA · Hizentra · Horizant · INBRIJA · KISUNLA · LYRICA · Leqembi · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · PONVORY · Privigen · QULIPTA · QUVIVIQ · RELEXXII · REXULTI · REYVOW · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Spritam · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · Tymlos · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XYREM · XYWAV · Xeomin · Xyrem · ZTLido · Zilbrysq
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a neurology specialist in Swedesboro?
Compare neurologists in the Swedesboro area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists in nearby ZIP areas
488
County median income
$102,807
Nearest hospital to ZIP centroid (approximate)
CROZER CHESTER MEDICAL CENTER
6.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wilford is a mixed practice specialist, with above-average Medicare volume (top 13% in NJ), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wilford experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Wilford performed 4,100 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wilford receive payments from pharmaceutical companies?
Yes. Dr. Wilford received a total of $12,750 from 77 companies across 769 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wilford's costs compare to other neurologists in Swedesboro?
Dr. Wilford's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wilford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →